Patents by Inventor Eric Eggers

Eric Eggers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11707198
    Abstract: The disclosure provides wearable cardiac arrest detection and alerting device that incorporates a non-invasive sensor based on optical and/or electrical signals transmitted into and received from human tissue containing blood vessels, and that transcutaneously quantifies the wearer's heart rate. The heart-rate quantification enables the detection of the absence of any heart beat by the wearable detection and alerting device indicative of the occurrence of a cardiac arrest, wherein the heart is no longer achieving effective blood circulation in the individual wearing the device. The display on the wearable cardiac arrest detection and alerting device may include the elapsed time since the time of detection of a heart rate that is below a predetermine lower limit value, i.e., the detected occurrence of a cardiac arrest event.
    Type: Grant
    Filed: September 29, 2021
    Date of Patent: July 25, 2023
    Assignee: Eggers & Associates, LLC
    Inventors: Philip E. Eggers, Eric A. Eggers, Benjamin Z. Bailey, Andrew Eggers
  • Publication number: 20220022758
    Abstract: The disclosure provides wearable cardiac arrest detection and alerting device that incorporates a non-invasive sensor based on optical and/or electrical signals transmitted into and received from human tissue containing blood vessels, and that transcutaneously quantifies the wearer's heart rate. The heart-rate quantification enables the detection of the absence of any heart beat by the wearable detection and alerting device indicative of the occurrence of a cardiac arrest, wherein the heart is no longer achieving effective blood circulation in the individual wearing the device. The display on the wearable cardiac arrest detection and alerting device may include the elapsed time since the time of detection of a heart rate that is below a predetermine lower limit value, i.e., the detected occurrence of a cardiac arrest event.
    Type: Application
    Filed: September 29, 2021
    Publication date: January 27, 2022
    Applicant: Eggers & Associates, Inc.
    Inventors: Philip E. Eggers, Eric A. Eggers, Benjamin Z. Bailey, Andrew Eggers
  • Patent number: 11219373
    Abstract: The disclosure provides wearable cardiac arrest detection and alerting device that incorporates a non-invasive sensor based on optical and/or electrical signals transmitted into and received from human tissue containing blood vessels, and that transcutaneously quantifies the wearer's heart rate. The heart-rate quantification enables the detection of the absence of any heart beat by the wearable detection and alerting device indicative of the occurrence of a cardiac arrest, wherein the heart is no longer achieving effective blood circulation in the individual wearing the device. The display on the wearable cardiac arrest detection and alerting device may include the elapsed time since the time of detection of a heart rate that is below a predetermine lower limit value, i.e., the detected occurrence of a cardiac arrest event.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: January 11, 2022
    Assignee: Eggers & Associates, Inc.
    Inventors: Philip E. Eggers, Eric A. Eggers, Andrew Eggers, Benjamin A. Bailey
  • Publication number: 20180132722
    Abstract: A scan completeness auditing system for screening a volume of tissue comprising a manual image scanning device having an imaging probe, a position tracking system configured to track and record the position of the imaging probe during use, and a controller in communication with the recording system and the manual image scanning device, the controller configured to electronically receive and record the scanned images from the manual image scanning device, and to measure an image-to-image spacing and a scan-to-scan spacing between the scanned images within scan sequence and between scan sequences respectively. The scan completeness auditing system is further adapted to provide an alert to the operator if the image-to-image or scan-to-scan spacing exceeds an acceptable value.
    Type: Application
    Filed: June 27, 2017
    Publication date: May 17, 2018
    Inventors: Philip E. EGGERS, Scott P. HUNTLEY, Eric A. EGGERS, Bruce A. ROBINSON
  • Publication number: 20170172424
    Abstract: The disclosure provides wearable cardiac arrest detection and alerting device that incorporates a non-invasive sensor based on optical and/or electrical signals transmitted into and received from human tissue containing blood vessels, and that transcutaneously quantifies the wearer's heart rate. The heart-rate quantification enables the detection of the absence of any heart beat by the wearable detection and alerting device indicative of the occurrence of a cardiac arrest, wherein the heart is no longer achieving effective blood circulation in the individual wearing the device. The display on the wearable cardiac arrest detection and alerting device may include the elapsed time since the time of detection of a heart rate that is below a predetermine lower limit value, i.e., the detected occurrence of a cardiac arrest event.
    Type: Application
    Filed: May 18, 2016
    Publication date: June 22, 2017
    Applicant: Eggers & Associates, Inc.
    Inventors: Philip E. Eggers, Eric A. Eggers, Andrew Eggers, Benjamin A. Bailey
  • Publication number: 20160174857
    Abstract: The disclosure provides a wearable cardiac arrest detection and alerting device that incorporates a non-invasive sensor based on optical and/or electrical signals transmitted into and received from human tissue containing blood vessels, and that transcutaneously quantifies the wearer's heart rate. The heart-rate quantification enables the detection of the absence of any heart beat by the wearable detection and alerting device indicative of the occurrence of a cardiac arrest, wherein the heart is no longer achieving effective blood circulation in the individual wearing the device. The display on the wearable cardiac arrest detection and alerting device may include the elapsed time since the time of detection of a heart rate that is below a predetermine lower limit value, i.e., the detected occurrence of a cardiac arrest event.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 23, 2016
    Applicant: Eggers & Associates, Inc.
    Inventors: Philip E. Eggers, Eric A. Eggers, Benjamin Z. Bailey
  • Publication number: 20160100821
    Abstract: A scan completeness auditing system for use with an ultrasound imaging console in screening a volume of tissue comprising a location tracking system comprising at least one position sensor adapted to couple to an imaging probe and at least one orientation sensor adapted to couple to the probe, the position and orientation sensors configured to provide data corresponding to the position and orientation of the imaging probe and a receiver comprising a controller configured to receive the position and orientation data from the location tracking system and to electronically receive and record a first scan sequence comprising a first set of scanned images representing cross-sections of the tissue from the imaging probe. The controller can be configured to assign a replay dwell time to each image in the scan sequence. The dwell time for each image can be based on a relative spacing for that image in the scan sequence.
    Type: Application
    Filed: April 29, 2014
    Publication date: April 14, 2016
    Inventors: Philip E. EGGERS, Scott P. HUNTLEY, Eric A. EGGERS, Bruce A. ROBINSON
  • Publication number: 20150366535
    Abstract: A scan completeness auditing system for use with an imaging console in screening a volume of tissue comprising a position tracking system configured to track and record a position of a manual imaging probe. The position tracking system com prises a plurality of cameras adapted to couple to the manual imaging probe and configured to provide position data for the manual imaging probe. The scan completeness auditing system includes a receiver comprising a controller-configured to electronically receive position data for the manual ultrasonic imaging probe from the position tracking system and to electronically receive and record a first scan sequence comprising a first set of scanned images representing cross-sections of the tissue from the manual imaging probe. The controller can be configured to compute an image-to-image spacing between successive images within the first scan sequence and to determine whether the computed image-to-image spacing exceeds a maximum limit.
    Type: Application
    Filed: January 16, 2014
    Publication date: December 24, 2015
    Inventors: Philip E. EGGERS, Scott P. HUNTLEY, Eric A. EGGERS, Bruce A. ROBINSON
  • Publication number: 20150213725
    Abstract: Systems and methods are disclosed for reviewing multiple images while monitoring a reviewer's attentiveness during the review. Systems include an image review system configured to output a series of images to the display and a user attention monitoring system configured to monitor at least one attention parameter for a user during the user's review and to generate user attention data based on the at least one attention parameter monitored, wherein the image review system is configured to output the second image to the display if the user attention data indicates sufficient user attentiveness. The image review system may also be configured to generate distraction or review breaks during the review period.
    Type: Application
    Filed: August 28, 2013
    Publication date: July 30, 2015
    Inventors: Scott P. Huntley, Bruce A. Robinson, Philip E. Eggers, Eric A. Eggers, Gerald R. Kolb
  • Publication number: 20140276034
    Abstract: A system, and apparatus for detecting and quantifying circulatory anomalies, including right-to-left cardiac shunts. The apparatus implements a sensor system useful in connection with a circulatory indicator delivery system. The sensor apparatus is preferably configured with a series of emitter/detector pairs to optimize the sensitivity of detection of the circulating indicator. Sensing of the indicator concentration takes place at an arterial vasculature, for example, the pinna of the human ear. A monitor/controller calculates and displays a indicator/dye dilution curve to assess for the presence of a cardiac shunt. The monitor/controller further corrects the indicator/dilution curve displayed for any recirculation phenomena and can quantify any right-to-left shunt calculated conductance associated with detected shunts.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: Cardiox Corporation
    Inventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers
  • Publication number: 20140128733
    Abstract: Systems and methods for detecting circulatory anomalies such as, for example, right-to-left cardiac and pulmonary shunts. A fluorescing indicator is injected into the bloodstream of a subject. An optical sensor is used to transcutaneously excite the indicator into fluorescence and to transcutaneously detect the fluorescence, and a relative concentration of the indicator is determined as a function of time. An indicator dilution curve is generated from the relative concentration readings, the curve shape is analyzed for the indication of a shunt and, if a shunt is detected, a ratiometric area under the curve analysis is performed and combined with a calculated cardiac output value to provide a shunt conductance value. A Valsalva maneuver may be performed as a part of the method. System embodiments may include a controller/monitor that monitors, times, cues and/or analyzes various steps of a shunt detection test.
    Type: Application
    Filed: December 9, 2013
    Publication date: May 8, 2014
    Applicant: CARDIOX CORPORATION
    Inventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers
  • Publication number: 20130225986
    Abstract: A scan completeness auditing system for screening a volume of tissue comprising a manual image scanning device having an imaging probe, a position tracking system configured to track and record the position of the imaging probe during use, and a controller in communication with the recording system and the manual image scanning device, the controller configured to electronically receive and record the scanned images from the manual image scanning device, and to measure an image-to-image spacing and a scan-to-scan spacing between the scanned images within scan sequence and between scan sequences respectively. The scan completeness auditing system is further adapted to provide an alert to the operator if the image-to-image or scan-to-scan spacing exceeds an acceptable value.
    Type: Application
    Filed: April 1, 2013
    Publication date: August 29, 2013
    Inventors: Philip E. Eggers, Scott P. Huntley, Eric A. Eggers, Bruce A. Robinson
  • Publication number: 20120330116
    Abstract: A system, method and apparatus are disclosed for using a transcutaneous detection system to measure the quantity of a circulating organ activity detection analyte in the blood, and thereby assay the activity of an organ. A preferred organ for assay is the human liver and a preferred indicator is indocyanine green (ICG) dye The procedure is under the control of a monitor/controller having a visual display and capable of providing cues to the operator. A sensor array apparatus for use in conjunction with the system monitor/controller is configured for increased sensitivity of assaying organ function.
    Type: Application
    Filed: August 29, 2012
    Publication date: December 27, 2012
    Applicant: CARDIOX CORPORATION
    Inventors: Philip E. Eggers, Eric A. Eggers, Andrew R. Eggers, Mark A. Mayerchak
  • Publication number: 20110245662
    Abstract: The invention generally relates to a system, method and apparatus for detection of circulatory anomalies in the mammalian body. Particularly, apparatus is provided that allows the clinician to quantitatively determine the extent of any anomalies in the pulmonary circulation. Specifically a quantifiable agent is injected into a peripheral location, and the transit of the indicator agent is monitored. Aberrant circulation is them quantified. The preferred indicator is an injection of indocyanine green dye, detected and measured by fluorescence at a sensor location, for example, at the human ear. Quantification is carried out by using cardiac output procedures and alternatively, the use of Valsalva Maneuver is monitored at a monitor/controller providing visual cues to the patient and operator.
    Type: Application
    Filed: April 6, 2010
    Publication date: October 6, 2011
    Inventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers, Michael W. Jopling
  • Patent number: 7920926
    Abstract: Implant apparatus and method for effecting a controlled heating of tissue within the region of dermis of skin. The heater implants are configured with a thermally insulative generally flat support functioning as a thermal barrier. One surface of this thermal barrier carries one or more polymerically encapsulated heater resistor segments with a lead assemblage exhibiting a 4-point topology. Each of the encapsulated heater segments may be thermally associated with a metal thermal spreader dimensioned in correspondence with and aligned with the heater segments. The implants are located within heating channels at the interface between skin dermis and the next adjacent subcutaneous tissue layer such that the heat spreaders are contactable with the lower region of dermis. During therapy a conformal heat sink is positioned against the skin above the implants and a slight tamponade is applied through the heat sink to assure a proper form of conduction heat transfer.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: April 5, 2011
    Assignee: Apsara Medical Corporation
    Inventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers
  • Publication number: 20100016731
    Abstract: The preferred indicator is an injection of indocyanine green dye which is detected and quantified by causing it to fluoresce at a sensor location, for example, at the human ear. Quantification is carried out by using cardiac output procedures and where called for, the Valsalva Maneuver is monitored at a monitor/controller giving visual cues to the patient and operator as to the quality of the necessary exhalation pressure maintenance.
    Type: Application
    Filed: April 6, 2009
    Publication date: January 21, 2010
    Applicant: Cardiox Corporation
    Inventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers
  • Publication number: 20090292177
    Abstract: A target tissue volume is accessed with a cannular instrument, the tip surface of which supports a precursor electrode assemblage which is electrosurgically excitable. The instrument tip initially is inserted through an incision made in the skin of a patient utilizing a pair of retractor components, the tips of which are located at a proper depth for positioning the precursor electrodes of the recovery instrument. The retractor components also are configured to define a guidance channel for receiving the tip of the recovery instrument. By stabilizing the instrument when the precursor electrodes are adjacent the tips of the retractor components and then slidably removing the retractor apparatus along the surface of the instrument, the tissue is “set” to assure proper precursor electrode positioning.
    Type: Application
    Filed: September 5, 2002
    Publication date: November 26, 2009
    Inventors: Philip E. Eggers, Eric A. Eggers, Andrew R. Eggers
  • Publication number: 20090149852
    Abstract: Method, system and apparatus for carrying out accurate electrosurgical cutting. A thin resilient electrode is utilized at the forward end region of an instrument that is deployable from a longitudinally disposed slot positioned rearwardly of the tip of the instrument. Lateral sides of the slot extend between a forward location adjacent the tip and a rearward location. The electrode is deployed by urging it forwardly in compression to form an arch profile supported by the abutting slot sides adjacent the forward and rearward locations. Electrosurgically excitable with a cutting output, the electrode may carry out a cutting action both during its deployment and retraction into the noted slot. This permits a pivoting maneuver effective for circumscribing a volume of targeted tissue.
    Type: Application
    Filed: February 16, 2009
    Publication date: June 11, 2009
    Applicant: Intact Medical Corporation
    Inventors: Philip E. Eggers, Eric A. Eggers, Andrew R. Eggers
  • Patent number: 7494473
    Abstract: Electrosurgical tissue specimen recovery apparatus and system employing a multi-leaf capture component configured with pursing cables which are electrosurgically excited to define a cutting leading edge. To complete a capture, the cables are loaded in tension to purse and thus converge the tips of the capture component leafs together. The forward regions of the leafs are configured with a combination of a thin flat stainless steel region over which a polymeric cable guide is positioned. The polymeric cable guide and stainless steel leaf driving combination improves frictional aspects as well as the resulting aspect ratio of a recovered tissue specimen.
    Type: Grant
    Filed: December 8, 2003
    Date of Patent: February 24, 2009
    Assignee: Intact Medical Corp.
    Inventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers
  • Publication number: 20080097557
    Abstract: Implant apparatus and method for effecting a controlled heating of tissue within the region of dermis of skin. The heater implants are configured with a thermally insulative generally flat support functioning as a thermal barrier. One surface of this thermal barrier carries one or more electrodes within a radiofrequency excitable circuit as well as an associated temperature sensing circuit. The implants are located within heating channels at the interface between skin dermis and the next adjacent subcutaneous tissue layer such that the electrodes are contactable with the lower region of dermis. During therapy a conformal heat sink is positioned against the skin above the implants and a slight tamponade is applied through the heat sink to assure uniform dermis contact with electrode surfaces. An adjuvant may be employed to infiltrate dermis to significantly lower the thermal threshold transition temperature for dermis or dermis component shrinkage.
    Type: Application
    Filed: October 19, 2006
    Publication date: April 24, 2008
    Applicant: Apsara Medical Corporation
    Inventors: Philip E. Eggers, Andrew R. Eggers, Eric A. Eggers